‹ SUPN latest research

SUPN (Supernus Pharmaceuticals, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed SUPN on 3 market nights between November 2, 2026 and November 4, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

3 calls 0 BUY · 3 HOLD · 0 SELL
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
November 4, 2026 HOLD $28.15 — / — not yet not yet
The current market and stock conditions do not warrant a buy.
November 3, 2026 HOLD $41.92 $48.21 / $35.63 not yet not yet
The technical picture is bearish, and the risk score is high, suggesting a short-term holding period if a trade were initiated.
November 2, 2026 HOLD $41.92 — / — not yet not yet
The current market regime and the stock's technicals do not support a buy decision at this time.

Related stocks

REPL Replimune Group, Inc.OMCL Omnicell, Inc.NTRA Natera, Inc.KNSA Kiniksa Pharmaceuticals InteFTRE Fortrea Holdings Inc.ELV Elevance Health, Inc.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated November 5, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.